Continuous Administration of Morphine for Terminal Interstitial Pneumonia Patients with or Without Cancer: A Single Center Retrospective Study

被引：0
|
作者：
Okabayashi, H. [1 ]
Kitamura, H. [1 ]
Harada, T. [2 ]
Yamaguchi, A. [3 ]
Horikoshi, M. [3 ]
Yamaguchi, K. [3 ]
Nakagawa, H. [3 ]
Asaoka, M. [1 ]
Isomoto, K. [1 ]
Sekine, A. [1 ]
Baba, T. [1 ]
Komatsu, S. [1 ]
Hagiwara, E. [1 ]
Matsuo, R. [3 ]
Ogura, T. [1 ]
机构：
[1] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan
[2] Kanagawa Cardiovasc & Resp Ctr, Dept Pharm, Yokohama, Kanagawa, Japan
[3] Kanagawa Cardiovasc & Resp Ctr, Nursing Dept, Yokohama, Kanagawa, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4768
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study
    Zhang, Qing
    Gao, Hao-Yang
    Li, Ding
    Li, Zheng
    Qi, Shan-Shan
    Zheng, Shan
    Bai, Chang-Sen
    Zhang, Si-He
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 359 - 371
  • [42] The use of intravenous morphine for breakthrough pain in terminal cancer patients admitted to hospice center
    Chung, Ik-Joo
    Cho, Sang-Hee
    Hwang, Jun-Eul
    Ahn, Jae-Sook
    Choi, Won-young
    Shim, Hyun-Jeong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
    Okabayashi, Hiroko
    Kitamura, Hideya
    Ikeda, Satoshi
    Sekine, Akimasa
    Oda, Tsuneyuki
    Baba, Tomohisa
    Hagiwara, Eri
    Sakagami, Takuro
    Ogura, Takashi
    PALLIATIVE MEDICINE REPORTS, 2021, 2 (01): : 188 - 193
  • [44] Adverse Drug Reactions in Japanese Patients with End-Stage Heart Failure Receiving Continuous Morphine Infusion: A Single-Center Retrospective Cohort Study
    Masayuki Gotou
    Atsushi Suzuki
    Tsuyoshi Shiga
    Rumi Wakabayashi
    Mayui Nakazawa
    Noriko Kikuchi
    Nobuhisa Hagiwara
    Drugs - Real World Outcomes, 2022, 9 : 1 - 8
  • [45] Adverse Drug Reactions in Japanese Patients with End-Stage Heart Failure Receiving Continuous Morphine Infusion: A Single-Center Retrospective Cohort Study
    Gotou, Masayuki
    Suzuki, Atsushi
    Shiga, Tsuyoshi
    Wakabayashi, Rumi
    Nakazawa, Mayui
    Kikuchi, Noriko
    Hagiwara, Nobuhisa
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 1 - 8
  • [46] Lymphocytic interstitial pneumonia characterized by diffuse cystic lung lesions: Single-center, cohort retrospective analysis
    Zhao, Zhen
    Liang, Panqiao
    Liu, Jie
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [47] Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study
    Hur, Joon Young
    Kim, Youjin
    Kwon, Ghee-Young
    Kang, Minyong
    Sung, Hyun Hwan
    Jean, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jean, Seong Soo
    Lee, Hyun Moo
    Lee, Su Jin
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2019, 51 (04): : 1269 - 1274
  • [48] A SINGLE-CENTER RETROSPECTIVE STUDY OF CHEMOTHERAPY IN PATIENTS WITH SMALL CELL LUNG CANCER
    Fujitani, Y.
    Koh, G.
    ANNALS OF ONCOLOGY, 2013, 24 : 78 - 78
  • [49] A Retrospective Cohort Study Comparing Autoantibody Positive Idiopathic Interstitial Pneumonia Patients With And Without Extrathoracic Features Of Connective Tissue Disease
    Pereira, D. A. S.
    Almeida, G. E.
    Freitas, C. S.
    Dias, O. M.
    Araujo, M. S.
    Kawano-Dourado, L.
    Kawassaki, A. M.
    Baldi, B. G.
    Carvalho, C. R. R.
    Kairalla, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [50] Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study
    Hyun, Dong-gon
    Han, Soo Jin
    Ji, Wonjun
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Ho Cheol
    THORACIC CANCER, 2023, 14 (33) : 3323 - 3330
12345